Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
OncoMed Pharmaceuticals, a biotech developing new antibody therapeutics to be used in cancer treatments, raised the proposed deal size for its upcoming IPO on Wednesday. The Redwood City, CA-based company now plans to raise $72 million by offering 4.8 million shares at a price range of $14 to $16. The company had previously filed to offer 4.0 million shares at the same range.
Help employers find you! Check out all the jobs and post your resume.
OncoMed Pharmaceuticals, a biotech developing new antibody therapeutics to be used in cancer treatments, raised the proposed deal size for its upcoming IPO on Wednesday. The Redwood City, CA-based company now plans to raise $72 million by offering 4.8 million shares at a price range of $14 to $16. The company had previously filed to offer 4.0 million shares at the same range.
Help employers find you! Check out all the jobs and post your resume.
